Pages that link to "Q71332507"
Jump to navigation
Jump to search
The following pages link to Role of aggregated human growth hormone (hGH) in development of antibodies to hGH (Q71332507):
Displaying 50 items.
- Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications (Q26738810) (← links)
- Immunogenicity to Biotherapeutics - The Role of Anti-drug Immune Complexes (Q26766424) (← links)
- Protein comparability assessments and potential applicability of high throughput biophysical methods and data visualization tools to compare physical stability profiles (Q26998787) (← links)
- Influence of aggregation and route of injection on the biodistribution of mouse serum albumin (Q28538961) (← links)
- Protein formulation and fill-finish operations. (Q30332236) (← links)
- Structural characterization and immunogenicity in wild-type and immune tolerant mice of degraded recombinant human interferon alpha2b. (Q30351459) (← links)
- On the Role of Aggregates in the Immunogenicity of Recombinant Human Interferon Beta in Patients with Multiple Sclerosis (Q30394156) (← links)
- Effect of excipients on the stability and structure of lyophilized recombinant human growth hormone (Q30431933) (← links)
- Immunogenicity and other problems associated with the use of biopharmaceuticals (Q33416851) (← links)
- Simulations of reversible protein aggregate and crystal structure (Q34018003) (← links)
- Treatment of growth hormone deficiency (Q34039196) (← links)
- Simulations of kinetically irreversible protein aggregate structure (Q34115206) (← links)
- High hydrostatic pressure as a tool to study protein aggregation and amyloidosis (Q34620068) (← links)
- Bioequivalence and the immunogenicity of biopharmaceuticals (Q34742161) (← links)
- Strategies for detection, measurement and characterization of unwanted antibodies induced by therapeutic biologicals (Q35212578) (← links)
- The oligosaccharides of glycoproteins: bioprocess factors affecting oligosaccharide structure and their effect on glycoprotein properties (Q35292620) (← links)
- Minimizing the immunogenicity of protein therapeutics (Q35687687) (← links)
- Structure-immunogenicity relationships of therapeutic proteins (Q35814108) (← links)
- Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation (Q36116861) (← links)
- Immunogenicity of different stressed IgG monoclonal antibody formulations in immune tolerant transgenic mice (Q36411853) (← links)
- Effects of protein aggregates: an immunologic perspective (Q36616319) (← links)
- Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals (Q36616358) (← links)
- High pressure fosters protein refolding from aggregates at high concentrations (Q36665337) (← links)
- O-phospho-L-serine, multi-functional excipient for B domain deleted recombinant factor VIII. (Q36950100) (← links)
- Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A mice (Q36951646) (← links)
- How to predict and prevent the immunogenicity of therapeutic proteins (Q37209122) (← links)
- Autologous albumin enhances the humoral immune response to capsular polysaccharide covalently coattached to bacteria-sized latex beads (Q37732367) (← links)
- Growth hormone therapy for short stature: panacea or Pandora's box? (Q37941317) (← links)
- Biochemical and biophysical characterization of humanized IgG1 produced in Pichia pastoris (Q37952121) (← links)
- Immunogenicity of therapeutic proteins: influence of aggregation (Q38126938) (← links)
- Development of interferon-gamma antagonists as an example of biotechnology application to approach new immunomodulators (Q38262538) (← links)
- Immunogenicity of Therapeutic Protein Aggregates (Q38730609) (← links)
- Mouse Models for Assessing Protein Immunogenicity: Lessons and Challenges (Q38798188) (← links)
- Mechanisms of m-cresol-induced protein aggregation studied using a model protein cytochrome c. (Q39164829) (← links)
- Advances in diagnosis and treatment of short stature, with special reference to the role of growth hormone (Q40212195) (← links)
- Effect of growth hormone and IgG aggregates on dendritic cells activation and T-cells polarization. (Q40514614) (← links)
- Recombinant human growth hormone poly(lactic-co-glycolic acid) microsphere formulation development (Q40762790) (← links)
- Physical characterization and in vitro biological impact of highly aggregated antibodies separated into size-enriched populations by fluorescence-activated cell sorting (Q41353938) (← links)
- Toward understanding insulin fibrillation (Q41466059) (← links)
- Visual Detection of Denatured Glutathione Peptides: A Facile Method to Visibly Detect Heat Stressed Biomolecules (Q41880923) (← links)
- Raman spectroscopy characterization of antibody phases in serum (Q42177409) (← links)
- Effect of freezing on aggregation of human growth hormone (Q43954952) (← links)
- Identification of Aggregates in Therapeutic Formulations of Recombinant Full-Length Factor VIII Products by Sedimentation Velocity Analytical Ultracentrifugation. (Q45875342) (← links)
- Significance of unfolding thermodynamics for predicting aggregation kinetics: a case study on high concentration solutions of a multi-domain protein (Q46949891) (← links)
- Assessment of the antigenic response in humans to a recombinant mutant interferon beta (Q46959396) (← links)
- Arginine as an Excipient for Protein Freeze-Drying: A Mini Review (Q47355384) (← links)
- Self-interaction chromatography: a tool for the study of protein-protein interactions in bioprocessing environments (Q47863270) (← links)
- Flow microscopy imaging is sensitive to characteristics of subvisible particles in peginesatide formulations associated with severe adverse reactions (Q50153560) (← links)
- Neutralization of the biological activity of cytokines and other protein effectors by antibody: theoretical formulation of antibody titration curves in relation to antibody affinity. (Q52009627) (← links)
- Effects of insulin concentration and self-association on the partitioning of its A-21 cyclic anhydride intermediate to desamido insulin and covalent dimer. (Q52338093) (← links)